Pfizer Sees Tax Savings From AstraZeneca Deal

Pfizer’s nearly $100 billion offer to buy British rival AstraZeneca, if accepted, would allow the pharmaceutical giant to move its official headquarters overseas, saving it billions in taxes.

Leave a Reply

Your email address will not be published. Required fields are marked *